Publications

GRK-biased adrenergic agonists for the treatment of type 2 diabetes and obesity

 30
GRK-biased adrenergic agonists for the treatment of type 2 diabetes and obesity

Tags:

Previous Article

Oncogene mutation in colorectal cancer leads to metabolic reprogramming

Next Article

GRK-biased adrenergic agonists for the treatment of type 2 diabetes and obesity

Related Posts

Gene therapy for chronic pain management

Gene therapy for chronic pain management

 59

Amygdalo-cortical dialogue underlies memory enhancement by emotional association

Amygdalo-cortical dialogue underlies memory enhancement...

 98

Timing and trajectory of BCR::ABL1-driven chronic myeloid leukaemia

Timing and trajectory of BCR::ABL1-driven chronic myelo...

 46